8-K
Current Report
Aldeyra Therapeutics, Inc. Filed Acc 0001213900-25-032947
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea023875601-8k_aldey.htm…